These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 24355041)

  • 1. Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties.
    Lin X; Li J; Yin G; Zhao Q; Elias D; Lykkesfeldt AE; Stenvang J; Brünner N; Wang J; Yang H; Bolund L; Ditzel HJ
    Breast Cancer Res; 2013 Dec; 15(6):R119. PubMed ID: 24355041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer.
    Giannoudis A; Malki MI; Rudraraju B; Mohhamed H; Menon S; Liloglou T; Ali S; Carroll JS; Palmieri C
    Breast Cancer Res; 2020 Nov; 22(1):126. PubMed ID: 33198803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone-tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells.
    Gaballah AI; Elsherbiny AA; Sharaky M; Hamed NO; Raslan NA; Almilaibary A; Fayyad RMA; Ousman MS; Hamdan AME; Fahim SA
    Biosci Rep; 2024 Jul; 44(7):. PubMed ID: 38864530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
    Phuong NT; Kim SK; Lim SC; Kim HS; Kim TH; Lee KY; Ahn SG; Yoon JH; Kang KW
    Breast Cancer Res Treat; 2011 Nov; 130(1):73-83. PubMed ID: 21170675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells.
    Wang B; Li D; Rodriguez-Juarez R; Farfus A; Storozynsky Q; Malach M; Carpenter E; Filkowski J; Lykkesfeldt AE; Kovalchuk O
    BMC Cancer; 2018 Aug; 18(1):817. PubMed ID: 30103729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
    Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells.
    Li G; Zhang J; Jin K; He K; Zheng Y; Xu X; Wang H; Wang H; Li Z; Yu X; Teng X; Cao J; Teng L
    Mol Oncol; 2013 Jun; 7(3):611-24. PubMed ID: 23499324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
    Phuong NT; Kim SK; Im JH; Yang JW; Choi MC; Lim SC; Lee KY; Kim YM; Yoon JH; Kang KW
    Oncotarget; 2016 Mar; 7(12):13902-16. PubMed ID: 26418898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties.
    Hu H; Sun J; Wang C; Bu X; Liu X; Mao Y; Wang H
    Biochem Biophys Res Commun; 2017 Apr; 485(3):643-650. PubMed ID: 28216163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional combination of resveratrol and tamoxifen to overcome tamoxifen-resistance in breast cancer cells.
    Radwan AM; Abosharaf HA; Sharaky M; Abdelmonem R; Effat H
    Arch Pharm (Weinheim); 2024 Oct; 357(10):e2400261. PubMed ID: 38943449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer.
    Joshi T; Elias D; Stenvang J; Alves CL; Teng F; Lyng MB; Lykkesfeldt AE; Brünner N; Wang J; Gupta R; Workman CT; Ditzel HJ
    Oncotarget; 2016 Aug; 7(35):57239-57253. PubMed ID: 27528030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen-resistant breast cancer cells possess cancer stem-like cell properties.
    Liu H; Zhang HW; Sun XF; Guo XH; He YN; Cui SD; Fan QX
    Chin Med J (Engl); 2013 Aug; 126(16):3030-4. PubMed ID: 23981606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lycorine weakens tamoxifen resistance of breast cancer via abrogating HAGLR-mediated epigenetic suppression on VGLL4 by DNMT1.
    Zhai J; Jiang JF; Shi L
    Kaohsiung J Med Sci; 2023 Mar; 39(3):278-289. PubMed ID: 36606584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear respiratory factor-1 and bioenergetics in tamoxifen-resistant breast cancer cells.
    Radde BN; Ivanova MM; Mai HX; Alizadeh-Rad N; Piell K; Van Hoose P; Cole MP; Muluhngwi P; Kalbfleisch TS; Rouchka EC; Hill BG; Klinge CM
    Exp Cell Res; 2016 Sep; 347(1):222-231. PubMed ID: 27515002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of BAG-1 expression alters the sensitivity of breast cancer cells to tamoxifen.
    Liu H; Lu S; Gu L; Gao Y; Wang T; Zhao J; Rao J; Chen J; Hao X; Tang SC
    Cell Physiol Biochem; 2014; 33(2):365-74. PubMed ID: 24557447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen resistance induction results in the upregulation of ABCG2 expression and mitoxantrone resistance in MCF-7 breast cancer cells.
    Ghalehno AD; Abdi H; Boustan A; Jamialahmadi K; Mosaffa F
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3723-3732. PubMed ID: 37310508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyoxometalate inhibition of SOX2-mediated tamoxifen resistance in breast cancer.
    Aurrekoetxea-Rodriguez I; Lee SY; Rábano M; Gris-Cárdenas I; Gamboa-Aldecoa V; Gorroño I; Ramella-Gal I; Parry C; Kypta RM; Artetxe B; Gutierrez-Zorrilla JM; Vivanco MD
    Cell Commun Signal; 2024 Sep; 22(1):425. PubMed ID: 39223652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer.
    Soleimani Dodaran M; Borgoni S; Sofyalı E; Verschure PJ; Wiemann S; Moerland PD; van Kampen AHC
    BMC Cancer; 2020 Jul; 20(1):676. PubMed ID: 32684154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells.
    Basak P; Chatterjee S; Bhat V; Su A; Jin H; Lee-Wing V; Liu Q; Hu P; Murphy LC; Raouf A
    Cell Physiol Biochem; 2018; 51(4):1518-1532. PubMed ID: 30497079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer.
    Stone A; Valdés-Mora F; Gee JM; Farrow L; McClelland RA; Fiegl H; Dutkowski C; McCloy RA; Sutherland RL; Musgrove EA; Nicholson RI
    PLoS One; 2012; 7(7):e40466. PubMed ID: 22808167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.